Effect of two-linked mutations of the FMO3 gene on itopride metabolism

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-14004390

Enrollment

Unknown

Registered

2014-02-23

Start date

2013-06-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

1:itopride

Eligibility

Sex/Gender

Male

Age

18 Years to 22 Years

Inclusion criteria

Inclusion criteria: 1. Aged 19 to 22 years; 2. Standard body mass index between 20 and 25 kg/m2; 3. The subjects were ascertained to be in good health by means of medical histories, physical and routine laboratory examinations, electrocardiograms.

Exclusion criteria

Exclusion criteria: All abstained from alcohol, took no medication, and were on a standard diet during the study.

Design outcomes

Primary

Measure	Time frame
concentration;	—

Countries

China

Contacts

Public ContactZhi-Rong Tan

Institute of Clinical Pharmacology

tanzr@163.com+86 0731-84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026